PMC:7283670 / 90905-91257 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T484","span":{"begin":113,"end":122},"obj":"Disease"},{"id":"T485","span":{"begin":123,"end":132},"obj":"Disease"},{"id":"T486","span":{"begin":260,"end":268},"obj":"Disease"},{"id":"T487","span":{"begin":343,"end":351},"obj":"Disease"}],"attributes":[{"id":"A484","pred":"mondo_id","subj":"T484","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A485","pred":"mondo_id","subj":"T485","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A486","pred":"mondo_id","subj":"T486","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A487","pred":"mondo_id","subj":"T487","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Multicenter clinical study on the efficacy and safety of Xiyanping injection in the treatment of new coronavirus infection pneumonia (general and severe) Drug: lopinavir/ritonavir tablets combined with Xiyanping injection drug: lopinavir/ritonavir treatment COVID‐19 80, all, 18–100 Treatment Experimental: experimental group of ordinary COVID‐19:"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T771","span":{"begin":279,"end":281},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"}],"text":"Multicenter clinical study on the efficacy and safety of Xiyanping injection in the treatment of new coronavirus infection pneumonia (general and severe) Drug: lopinavir/ritonavir tablets combined with Xiyanping injection drug: lopinavir/ritonavir treatment COVID‐19 80, all, 18–100 Treatment Experimental: experimental group of ordinary COVID‐19:"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T369","span":{"begin":161,"end":180},"obj":"Chemical"},{"id":"T370","span":{"begin":161,"end":170},"obj":"Chemical"},{"id":"T371","span":{"begin":171,"end":180},"obj":"Chemical"},{"id":"T372","span":{"begin":223,"end":227},"obj":"Chemical"},{"id":"T373","span":{"begin":229,"end":248},"obj":"Chemical"},{"id":"T374","span":{"begin":229,"end":238},"obj":"Chemical"},{"id":"T375","span":{"begin":239,"end":248},"obj":"Chemical"},{"id":"T376","span":{"begin":325,"end":330},"obj":"Chemical"}],"attributes":[{"id":"A369","pred":"chebi_id","subj":"T369","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A370","pred":"chebi_id","subj":"T370","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A371","pred":"chebi_id","subj":"T371","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A372","pred":"chebi_id","subj":"T372","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A373","pred":"chebi_id","subj":"T373","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A374","pred":"chebi_id","subj":"T374","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A375","pred":"chebi_id","subj":"T375","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"},{"id":"A376","pred":"chebi_id","subj":"T376","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"Multicenter clinical study on the efficacy and safety of Xiyanping injection in the treatment of new coronavirus infection pneumonia (general and severe) Drug: lopinavir/ritonavir tablets combined with Xiyanping injection drug: lopinavir/ritonavir treatment COVID‐19 80, all, 18–100 Treatment Experimental: experimental group of ordinary COVID‐19:"}

{"project":"LitCovid-sentences","denotations":[{"id":"T783","span":{"begin":0,"end":352},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Multicenter clinical study on the efficacy and safety of Xiyanping injection in the treatment of new coronavirus infection pneumonia (general and severe) Drug: lopinavir/ritonavir tablets combined with Xiyanping injection drug: lopinavir/ritonavir treatment COVID‐19 80, all, 18–100 Treatment Experimental: experimental group of ordinary COVID‐19:"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T263","span":{"begin":123,"end":132},"obj":"Phenotype"}],"attributes":[{"id":"A263","pred":"hp_id","subj":"T263","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Multicenter clinical study on the efficacy and safety of Xiyanping injection in the treatment of new coronavirus infection pneumonia (general and severe) Drug: lopinavir/ritonavir tablets combined with Xiyanping injection drug: lopinavir/ritonavir treatment COVID‐19 80, all, 18–100 Treatment Experimental: experimental group of ordinary COVID‐19:"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1967","span":{"begin":97,"end":112},"obj":"Species"},{"id":"2080","span":{"begin":161,"end":180},"obj":"Chemical"},{"id":"2081","span":{"begin":229,"end":248},"obj":"Chemical"}],"attributes":[{"id":"A1967","pred":"tao:has_database_id","subj":"1967","obj":"Tax:2697049"},{"id":"A2080","pred":"tao:has_database_id","subj":"2080","obj":"MESH:C558899"},{"id":"A2081","pred":"tao:has_database_id","subj":"2081","obj":"MESH:C558899"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Multicenter clinical study on the efficacy and safety of Xiyanping injection in the treatment of new coronavirus infection pneumonia (general and severe) Drug: lopinavir/ritonavir tablets combined with Xiyanping injection drug: lopinavir/ritonavir treatment COVID‐19 80, all, 18–100 Treatment Experimental: experimental group of ordinary COVID‐19:"}